Navigation Links
KV Pharmaceutical Forms Licensing Partnership with Gedeon Richter
Date:6/18/2009

ST. LOUIS and BUDAPEST, Hungary, June 18 /PRNewswire-FirstCall/ -- KV Pharmaceutical Company (NYSE: KVa/KVb) today announced that it has entered into an agreement with Gedeon Richter, Plc. of Budapest, Hungary, and jointly with Gedeon Richter USA for licensing rights to certain of KV's technologies and products in Women's Health. The agreement expands the parties' relationship and allows Gedeon Richter rights to manufacture and distribute certain of KV's proprietary technologies and products in its territories, including the European Union. KV Pharmaceutical will receive undisclosed milestones and royalties for products developed under the terms of the agreement.

The agreement also provides for the development of additional products in the future. KV retains the rights to the products and technology in the US.

David Van Vliet, interim CEO at KV Pharmaceutical Company said, "KV Pharmaceutical and Gedeon Richter have for many years enjoyed an excellent relationship and business collaboration and we are very pleased to extend it in this fashion. We believe this agreement allows both Richter and KV to offer additional enhanced products to more completely serve physicians and their patients."

Erik Bogsch, CEO of Gedeon Richter Plc. commented: "I am pleased to inform you about the extended cooperation between the two companies. We consider this agreement as an important step towards our strategy acquiring projects or products with high added value nature, as it allows us to enhance our existing female healthcare portfolio, not only in our traditional markets, but in all the EU member states. Present in-licensed products, as well as Richter's future proprietary development products will be produced at Richter's facilities based on KV's excellent technology platform."

About KV Pharmaceutical Company

KV Pharmaceutical Company is a fully integrated specialty pharmaceutical comp
'/>"/>

SOURCE KV Pharmaceutical Company
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
2. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
3. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
4. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
6. National Pharmaceutical Council Announces New Strategic Focus, Search for New Leadership
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
8. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
9. Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts Meeting September 28, 2007
10. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
11. Pharmaceutical Manufacturing Quality: Optimizing Your Internal Process for FDA Compliance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... ... 2015 , ... OncLive®’s extensive roster of Strategic ... Cancer Center (JCCC) mutually agreed to collaborate on projects that promote groundbreaking ... groups will help spread the news about the center’s leading-edge cancer research, robust ...
(Date:7/30/2015)... ... July 30, 2015 , ... Glidewell Laboratories, industry-leading provider of ... magazine, its multimedia publication focused on implant dentistry, is now available in print ... 6, Issue 2, as well as past issues of the dental laboratory’s quarterly ...
(Date:7/30/2015)... ... ... On July 23rd Clay Today Online reported the state of ... prison system, which has amassed largely enough throughout the years. Florida is the third ... Obama’s recent reduction of non violent drug offender’s prison sentences, Florida is beginning to ...
(Date:7/30/2015)... ... 30, 2015 , ... Gummy smile surgeon, Dr. Alex Farnoosh, now ... as well as the patented gum depigmentation treatmet. Dr. Farnoosh is a renowned dentist ... patients from around the world. , “Like treatment of any other disease or condition, ...
(Date:7/30/2015)... ... ... New research finds some distinct differences in the way mesothelioma behaves in younger ... website. , Researchers with the National Institutes of Health, the FDA, and the ... between 1990 and 2010. Two percent of these cases (207) occurred in people younger ...
Breaking Medicine News(10 mins):Health News:UCLA Jonsson Comprehensive Cancer Center Teams with OncLive® as a Strategic Alliance Partner 2Health News:UCLA Jonsson Comprehensive Cancer Center Teams with OncLive® as a Strategic Alliance Partner 3Health News:UCLA Jonsson Comprehensive Cancer Center Teams with OncLive® as a Strategic Alliance Partner 4Health News:Glidewell Laboratories Puts Out Latest Issue of Dental Implant Magazine Inclusive™ 2Health News:Glidewell Laboratories Puts Out Latest Issue of Dental Implant Magazine Inclusive™ 3Health News:Glidewell Laboratories Puts Out Latest Issue of Dental Implant Magazine Inclusive™ 4Health News:Florida Questions Its Spending on Punitive Incarceration in Light of Exorbitant Costs for Non Violent Offenders 2Health News:Florida Questions Its Spending on Punitive Incarceration in Light of Exorbitant Costs for Non Violent Offenders 3Health News:Gummy Smile Dentist, Alex Farnoosh DMD, is Now Offering Comprehensive Treatment Options for Gummy Smiles 2Health News:Study Finds Mesothelioma Behaves Differently in Younger People, According to Surviving Mesothelioma 2
... LEVERKUSEN, Germany and WEST HAVEN, Conn., Nov. 5 ... Drugs and,Medical Devices (BfArM), the U.S. Food and ... Bayer announced today that it,has elected to temporarily ... results from the Canadian BART trial can,be compiled, ...
... NATICK, Mass., Nov. 5 Boston Scientific,Corporation (NYSE: ... for the sale of its Cardiac Surgery and Vascular ... healthcare equipment,and systems. The transaction will be for a ... within the next 45-90 days, subject to regulatory,approvals and ...
... Funds But Many Fund,Trustees Say They Won,t Do Business With ... ... 5 More than five,hundred attendees at the International Foundation ... in the,opening hours of the convention on Sunday carrying bags ...
... TARRYTOWN, N.Y., Nov. 5 EpiCept Corporation,(Nasdaq: ... financial,results for the three and nine months ended September ... a net loss attributable to common,stockholders of $7.7 million, ... million, or $0.22 per basic and diluted share, for ...
... simplified treatment choices led to better outcomes, research ... Simplify. Simplify. Simplify. , New research shows this ... blood pressure, which is the leading risk factor ... to the future" approach to treating hypertension helped ...
... better when the dark delight is consumed, study suggests , ... A Japanese study finds that flavonoid-rich dark chocolate can improve ... as coronary flow velocity reserve (CFVR), an indicator of the ... blood flow in response to medications. , The two-week trial ...
Cached Medicine News:Health News:Bayer Temporarily Suspends Global Trasylol(R) Marketing 2Health News:Bayer Temporarily Suspends Global Trasylol(R) Marketing 3Health News:Bayer Temporarily Suspends Global Trasylol(R) Marketing 4Health News:Boston Scientific Announces Sale of Cardiac Surgery and Vascular Surgery Businesses 2Health News:Boston Scientific Announces Sale of Cardiac Surgery and Vascular Surgery Businesses 3Health News:Boston Scientific Announces Sale of Cardiac Surgery and Vascular Surgery Businesses 4Health News:Hundreds of Benefit Fund Trustees Question Viability of Rite Aid Pharmacy Benefit Management Company 2Health News:Hundreds of Benefit Fund Trustees Question Viability of Rite Aid Pharmacy Benefit Management Company 3Health News:Hundreds of Benefit Fund Trustees Question Viability of Rite Aid Pharmacy Benefit Management Company 4Health News:EpiCept Corporation Reports Third Quarter 2007 Operating and Financial Results 2Health News:EpiCept Corporation Reports Third Quarter 2007 Operating and Financial Results 3Health News:EpiCept Corporation Reports Third Quarter 2007 Operating and Financial Results 4Health News:EpiCept Corporation Reports Third Quarter 2007 Operating and Financial Results 5Health News:EpiCept Corporation Reports Third Quarter 2007 Operating and Financial Results 6Health News:EpiCept Corporation Reports Third Quarter 2007 Operating and Financial Results 7Health News:EpiCept Corporation Reports Third Quarter 2007 Operating and Financial Results 8Health News:EpiCept Corporation Reports Third Quarter 2007 Operating and Financial Results 9Health News:EpiCept Corporation Reports Third Quarter 2007 Operating and Financial Results 10Health News:New Measures Improve Heart Care 2Health News:New Measures Improve Heart Care 3Health News:New Measures Improve Heart Care 4Health News:Chocolate Has Sweet Effect on Blood Flow 2
(Date:7/30/2015)... 2015 P&S Market ... market overview, trends, DRO analysis, market segmentation, ... developments, competitive scenario and top competitor profiles ... Market Development and Demand Forecast to 2020  ... Explore more about global biosensors ...
(Date:7/30/2015)... , July 30, 2015   Gaumard® ... update to UNI®, the world,s first operating system ... is now available exclusively to Gaumard users. UNI® ... recently launched Newborn Tory™ S2200, as well as ... monitoring of clinical measures such as EtCO 2 ...
(Date:7/30/2015)... 30, 2015   Sentrian , the Remote ... hospitalization, recently received confirmation from the Food & ... (RPI) solution meets the definition of a "medical ... "Enforcement Discretion." The designation identifies ... FDA regulatory requirements at this time" and clears ...
Breaking Medicine Technology:Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 2Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 3Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 4Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 5Gaumard's Latest UNI Operating System Update Adds Performance and New Functionality 2Gaumard's Latest UNI Operating System Update Adds Performance and New Functionality 3FDA Clears Way for Commercial Marketing of Sentrian Remote Patient Intelligence Solution 2FDA Clears Way for Commercial Marketing of Sentrian Remote Patient Intelligence Solution 3
... , New England Journal of Medicine Publishes First ... Kidney Disease Patients "Superior" in Treating Blocked Access ... A randomized multicenter study of 190 patients at 13 ... grafts over balloon angioplasty for maintaining function of dialysis access ...
... SIGNAL HILL, Calif. , Feb. 11 Integrated ... care, announced that former United States Air Force Surgeon General ... Board of Advisors. , As U.S. Air Force Surgeon General, ... Secretary of the Air Force, and provided direction to over ...
Cached Medicine Technology:Stent Grafts Top "Gold Standard" Balloon Angioplasty for Dialysis Patients 2Stent Grafts Top "Gold Standard" Balloon Angioplasty for Dialysis Patients 3Stent Grafts Top "Gold Standard" Balloon Angioplasty for Dialysis Patients 4Stent Grafts Top "Gold Standard" Balloon Angioplasty for Dialysis Patients 5Stent Grafts Top "Gold Standard" Balloon Angioplasty for Dialysis Patients 6Former Air Force Surgeon General Joins Integrated Medical Systems' Advisory Board 2Former Air Force Surgeon General Joins Integrated Medical Systems' Advisory Board 3
Representing the next step in the evolution of point-of-care testing, the i-STAT 1 Analyzer uses one platform to perform glucose strip testing along with all i-STAT test cartridges....
... The Attain 4194 Bipolar over-the-wire left-heart lead ... This new steroid-eluting lead has an angled ... a guidewire or a stylet delivery method, ... maneuver and position the lead in a ...
... lamp Reserve lamp at the flip of a ... a reserve lamp in primary port Thermostatically ... certification Lamp out indicator lets you know ... lamp for quick replacement. Mobile five-caster stand with ...
Mounted on a fully adjustable molded,headband with crown strap and comfort,cushions, the sturdy Trueview Classic is,lightweight, comfortable and durable....
Medicine Products: